Arrowhead licenses liver disease drug to Madrigal for $25 million upfront
Go back to Arrowhead licenses liver disease drug to Madrigal for $25 million upfront| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 79.90 -2.1 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.00 | 52 Week High | $8.22 | |||
| Open | $80.00 | 52 Week Low | $3.07 | |||
| Day High | $82.53 | P/E | N/A | |||
| Day Low | $79.69 | EPS | $-1.30 | |||
| Volume | 1,393,550 | |||||
| (NASDAQ: MDGL) | Delayed: 513.43 +0.55 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $512.88 | 52 Week High | $18.24 | |||
| Open | $513.36 | 52 Week Low | $6.60 | |||
| Day High | $522.00 | P/E | N/A | |||
| Day Low | $507.57 | EPS | $0.00 | |||
| Volume | 266,384 | |||||
